Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iannucci, G.
Right arrow Articles by Filippi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iannucci, G.
Right arrow Articles by Filippi, M.
Right arrowPubmed/NCBI databases
*Genetics Home Reference
Medline Plus Health Information
*MRI Scans
Related Collections
Right arrow Genetics of Stroke
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Pathology of Stroke

(Stroke. 2001;32:643.)
© 2001 American Heart Association, Inc.


Original Contributions

Correlations Between Clinical Findings and Magnetization Transfer Imaging Metrics of Tissue Damage in Individuals With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy

G. Iannucci, MD; M. Dichgans, MD; M. Rovaris, MD; R. Brüning, MD; T. Gasser, MD; L. Giacomotti; T.A. Yousry, MD M. Filippi, MD

From the Neuroimaging Research Unit (G.I., M.R., L.G., M.F.), Department of Neuroscience, Scientific Institute Ospedale San Raffaele, Milan, Italy, and the Departments of Neurology (M.D., T.G.), Radiology (R.B.), and Neuroradiology (T.A.Y.), Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany.

Correspondence to Dr Massimo Filippi, Neuroimaging Research Unit, Department of Neuroscience, Scientific Institute Ospedale San Raffaele, Via Olgettina 60, 20132 Milan, Italy. E-mail filippi.massimo{at}hsr.it


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowSubjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background and Purpose—We obtained magnetization transfer imaging (MTI) scans from individuals with cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) (1) to investigate the presence, extent, and nature of pathology in white and gray matter outside proton density (PD)-visible lesions; (2) to quantify the degree of tissue damage occurring in lesions seen on PD-weighted scans; and (3) to correlate MTI-derived measures of disease burden with age, physical disability, and cognitive performance.

Methods—Dual-echo, T1-weighted, and MTI scans of the brain were obtained from 33 individuals with CADASIL and 12 control subjects. Magnetization transfer ratio (MTR) values from PD-visible lesions, normal-appearing white matter (NAWM), and normal-appearing gray matter (NAGM) were measured. Histograms of MTR from the whole brain and normal-appearing brain tissue were also produced.

Results—All MTR values from NAWM and NAGM regions studied were significantly lower for individuals with CADASIL than for control subjects, with the exception of those obtained from the NAWM of the infratentorial structures and the NAGM of the occipital cortex. The average MTR from PD lesions in individuals with CADASIL was significantly lower than that from all the NAWM regions. Average MTR and peak location from whole-brain and normal-appearing brain tissue histograms were significantly lower for individuals with CADASIL than for control subjects. MTR values from NAWM were strongly correlated with the extent of macroscopic lesions and their average MTR. Apart from NAGM, average MTR from all other tissues studied significantly decreased with increasing age, physical disability, and cognitive impairment.

Conclusions—PD lesions of individuals with CADASIL have variable degrees of tissue damage. Brain tissue outside PD abnormalities is also damaged. This study suggests that the extent and the severity of the brain tissue damage are critical factors in determining clinical status in CADASIL.


Key Words: CADASIL • magnetic resonance imaging • magnetization transfer imaging.


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowSubjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary disease of small arteries secondary to mutations within the Notch3 gene.1 Ultrastructural examination of small arteries reveals degenerating vascular smooth muscle cells along with characteristic granular deposits.2 3 Such arteriopathic changes have been documented in virtually all organs of patients with CADASIL, but they are more pronounced in the brain, where they can result in small circumscribed subcortical infarcts and confluent areas of diffuse white matter abnormalities.4 As shown by a number of MRI studies,5 6 7 8 9 10 11 conventional T2-weighted scans of the brain are very sensitive in detecting the presence of such lesions in the brain from individuals with CADASIL. However, conventional MR scanning allows only limited quantification of the degree of tissue destruction. Other MRI techniques, such as magnetization transfer imaging (MTI), may go some way toward overcoming this limitation.12

Contrast on MTI scans is based on the interactions between protons in a relatively free environment and in an environment in which motion is restricted.13 In the brain, these 2 states correspond to the protons in tissue water and in the macromolecules of myelin and other cell membranes. Off-resonance irradiation, which saturates the magnetization of the less mobile protons, is applied, but this is transferred to the mobile protons, thus reducing the signal intensity from the observable magnetization. The degree of signal loss depends on the density and nature of the macromolecules in a given tissue. However, the intensity of a region in an image obtained with magnetization transfer (MT) contrast also reflects, as a minimum, the proton density (PD) in that region and relaxation-based weighting (depending on the image acquisition parameter). For this reason, MT data are usually normalized to calculate an index of MT effect that is relatively independent of the other acquisition parameters. Common practice is to calculate the MT ratio (MTR).14 Low MTR indicates a reduced capacity of the macromolecules in brain tissue to exchange magnetization with the surrounding water molecules, thus reflecting matrix damage.13 MT characteristics can be analyzed on a region-of-interest (ROI) basis from maps of MTR, giving information about individual lesions or discrete areas of the normal-appearing white matter (NAWM) and normal-appearing gray matter (NAGM). The analysis of MT changes can also be performed on a more global basis by use of MTR histograms.15 This approach allows evaluation of all the MR image pixels corresponding to brain tissue, thus providing a complete assessment of changes at both macroscopic and microscopic levels.

In the present study, we obtained MTI scans from a relatively large sample of individuals with CADASIL (1) to investigate the presence, extent, and nature of pathology in white and gray matter outside PD-visible lesions; (2) to quantify the degree of tissue damage occurring in lesions seen on PD-weighted scans; and (3) to correlate MTI-derived measures of disease burden with age, physical disability, and cognitive performance of individuals with CADASIL.


*    Subjects and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Subjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Patients
Thirty-three individuals with CADASIL (12 women and 21 men; mean age 50 years, SD 10 years) from 25 families were included in the present study. In all the cases, the diagnosis was confirmed either by a skin or muscle biopsy (7 cases)3 16 or by the demonstration of a pathogenic mutation within the Notch3 gene (26 cases).17 Twenty-nine of the 33 individuals included in the study also had clinical manifestations of CADASIL, including (1) ischemic episodes, (2) cognitive deficits, (3) psychiatric symptoms, (4) migraine with aura, and (5) epileptic seizures, or they had variable combinations of all of the above.5 10 18 Disability was graded in all the individuals with CADASIL by use of the Rankin scale.19 This is a 5-point rating scale that grades patients on the basis of their overall level of independence with reference to previous performance. Grade 0 corresponds to the absence of symptoms, and grade 5 results from the presence of severe handicap and total dependence. In 29 individuals with CADASIL, cognitive performance was assessed by using the Structured Interview for the Diagnosis of the Alzheimer-Type, Multi-Infarct Dementia and Dementias of Other Etiology (SIDAM).20 The SIDAM comprises a brief structured clinical interview, a range of cognitive tests, which constitute a short neuropsychological battery, and a section for clinical judgment. The SIDAM score is inversely correlated with the severity of the patients’ cognitive impairment. The mean SIDAM score of our group of individuals with CADASIL was 44 (range 14 to 54). The remaining 4 individuals either refused to undergo neuropsychological evaluation or were not considered for it because of the presence of severe pseudobulbar palsy. Twelve healthy volunteers (4 women and 8 men) served as control subjects. Their mean age was 42.0 years (SD 8 years). Although age-matching between controls and individuals with CADASIL was not optimal, a previous study21 did not show significant MTR changes between men and women and for individuals aged 36 to 55 years. Local ethical committee approval and informed consent from all the subjects were obtained before inclusion in the study.

Magnetic Resonance Imaging
Brain MRI scans were obtained from all the subjects by use of a 1.5-Tesla system (Vision, Siemens). The following pulse sequences were acquired: (1) dual-echo turbo spin echo (repetition time [TR] 2300 ms, echo time [TE] 14/85 ms, and echo train length 5), (2) 2D gradient echo (GE) (TR 600, TE 7, and {alpha}=20°) with and without a saturation pulse (the saturation pulse was an off-resonance radiofrequency pulse centered 1.5 kHz below the water frequency, with a gaussian envelope and a bandwidth of 250 Hz and {alpha}=500°), and (3) T1-weighted spin echo (TR 530, TE 20). For all the scans, 20 contiguous axial slices were acquired with a 5-mm slice thickness and an in-plane spatial resolution of 0.9x0.9 mm. All the scans were positioned according to published guidelines.22

Image Review and Quantification
Dual-echo and T1-weighted hard copies from all individuals with CADASIL and control subjects were reviewed in a random order by agreement of 2 experienced observers who were unaware of to whom the scans belonged. Hyperintense lesions on PD scans and hypointense lesions on T1-weighted scans were identified and marked on the hard copies, as described previously.23 Lesion volume measurements were then performed by a single observer, again without knowledge of to whom the scans belonged, with use of a semiautomated segmentation technique based on local thresholding.23

From the 2 GE images, with and without the saturation pulse, MTR maps were derived according to a method described previously.15 23 After image coregistration, with use of a technique based on mutual information,24 the lesion outlines on the first echo images of the dual-echo scans were superimposed onto the MTR maps, and average lesion MTR was calculated for each subject, as reported elsewhere.23 For each MTR map and whenever possible, square ROIs (area 3x3 pixels) were placed bilaterally in areas of NAWM (cerebellar hemispheres, internal capsules, the white matter close to the anterior and posterior parts of the lateral ventricles, and the white matter close to the cortical gray matter of the sylvian fissures). Additional ROIs were also placed centrally in the NAWM of the pons and in areas of the NAGM corresponding to both deep gray matter and cortex regions (head of the caudate nucleus, putamen, thalamus, and frontal, temporal, parietal, and occipital cortex), which were analyzed separately. To be considered part of the NAWM or NAGM, an ROI must not have been adjacent to lesions visible on the same slice and on the slices above and below. ROIs were always placed with care to avoid partial volume effects from cerebrospinal fluid (CSF) and gray matter in the case of NAWM-ROIs and CSF and white matter in the case of NAGM-ROIs. Although GE images may be affected by susceptibility artifacts at the level of the skull base, the quality of our GE images was good, and we did not encounter any problem with image coregistration.

We also derived MTR histograms for the whole brain and normal-appearing brain tissue (NABT) from individuals with CADASIL and control subjects, as described previously.23 25 Using the same local thresholding technique that was used for lesion segmentation, a single observer, without knowledge of to whom the scans belonged, removed the skull and other extracranial tissues from the MTR maps. Then, MTR histograms for the whole-brain tissue were created. To obtain NABT-MTR histograms, the lesions segmented on the first echo images of the dual-echo scans were superimposed automatically onto the coregistered MTR map, and the areas corresponding to the segmented lesions were nulled out. For brain and NABT histograms, we excluded from the analysis all the pixels with MTR values <10% to eliminate CSF and points corresponding to noise alone. To correct for the between-patient differences in brain volume, each histogram was normalized by dividing it by the total number of pixels included. By doing this, the area under the histogram is made equal to unity for all subjects; thus, comparisons of the features that characterize the shape of the histogram can be made between subjects. For each MTR histogram, we analyzed the location of the histogram peak with respect to the x-axis (ie, the most common MTR within the brain), the height of the histogram peak, and the average MTR value.

In previous studies,26 27 we found very low intraobserver variabilities when we measured all the MRI and MTI quantities mentioned above.

Statistical Analysis
Differences in MTI parameters between CADASIL individuals and control subjects were assessed by a 2-tailed Student t test for nonpaired data, because MTR values had a normal distribution. Univariate correlations were performed by the Spearman rank correlation coefficient. To reflect the relatively large number of statistical comparisons, a value of P<=0.01 was considered significant, a value of P>=0.01 and <=0.05 was considered a significance trend, and values of P>0.05 were not considered significant. A multivariate analysis with age correction was also performed to assess the influence of PD lesion load, average lesion MTR, NAWM-MTR, cortical NAGM-MTR, and basal nuclei NAGM-MTR on physical disability (Rankin score) and cognitive impairment (SIDAM score). A logistic model was used when the Rankin score was considered (scores 0 to 2 versus scores 3 to 4), whereas a linear model was used when the SIDAM score was considered.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
*Results
down arrowDiscussion
down arrowReferences
 
All CADASIL individuals showed hyperintense PD-weighted and hypointense T1-weighted abnormalities. Mean lesion volumes were 70.5 mL (range 5.1 to 174.0 mL) on PD-weighted scans and 14.7 mL (range 0.1 to 65.7 mL) on T1-weighted scans.

Average MTR values from ROIs placed in the NAWM and NAGM of individuals with CADASIL and healthy control subjects are reported in Tables 1Down and 2Down. All values were significantly lower for individuals with CADASIL (P values ranging from 0.01 to 0.0001), with the exception of those obtained from the NAWM of the infratentorial structures (a significance trend was found for the MTR values of the pons) and those from the NAGM of the occipital cortex. Average lesion MTR in individuals with CADASIL was significantly lower than the average MTR from all the NAWM regions studied (P<0.0001). The average values of MTR histogram-derived measures from whole brain and NABT for individuals with CADASIL and control subjects are reported in Table 3Down. All MTR histogram-derived measures from whole brain and NABT were significantly lower for individuals with CADASIL than for healthy control subjects (P values ranging from 0.002 to 0.0001), with the exception of histogram peak heights. In individuals with CADASIL, the average MTR value from NABT was higher than that from the whole brain (P=0.003). The average MTR of NAWM was correlated (r values ranging from 0.52 to 0.79, P values ranging from 0.002 to <0.0001) with PD and T1 lesion volumes as well as with average lesion MTR. The average MTR of NAGM was correlated only with average lesion MTR (r=0.46, P<0.007) (Table 4Down).


View this table:
[in this window]
[in a new window]
 
Table 1. MTR From ROIs Placed in PD-Visible Lesions and NAWM Regions of 33 Individuals With CADASIL and 12 Healthy Control Subjects


View this table:
[in this window]
[in a new window]
 
Table 2. MTR From ROIs Placed in PD-Visible Lesions and NAGM Regions of 33 Individuals With CADASIL and 12 Healthy Control Subjects


View this table:
[in this window]
[in a new window]
 
Table 3. MTR Histogram-Derived Measures From Whole Brain and NABT of 33 Individuals With CADASIL and 12 Healthy Control Subjects


View this table:
[in this window]
[in a new window]
 
Table 4. Correlations Between Average MTR of NAWM and NAGM and Macroscopic Lesion Extent and Severity in 33 Individuals With CADASIL

In Table 5Down, the correlations between average MTR values from NAWM, NAGM, NABT, lesions, and whole brain and age, Rankin score, and SIDAM score from individuals with CADASIL are reported. Apart from NAGM, the average MTR from all other tissues studied significantly decreased with increasing age, increasing Rankin score, and decreasing SIDAM score (r values ranging from 0.42 to 0.59, P values ranging from 0.01 to 0.0001). The multivariate analysis showed that average lesion MTR was associated with both the Rankin (P=0.03, corrected for age) and the SIDAM (P=0.02, corrected for age) scores. All the other tested variables were excluded from the 2 models.


View this table:
[in this window]
[in a new window]
 
Table 5. Correlations Between MTR Quantities and Age, Rankin Score, and SIDAM Score in Individuals With CADASIL


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
up arrowResults
*Discussion
down arrowReferences
 
The present study shows that PD lesions in individuals with CADASIL have variable degrees of tissue destruction and that brain tissue outside PD abnormalities (both gray and white matter) is also damaged. It also shows that the overall lesion burden in CADASIL increases with age, degree of physical disability, and severity of cognitive impairment.

Our results indicate that MTR values from supratentorial NAWM are significantly lower in individuals with CADASIL than in normal subjects. The presence of white matter pathology beyond the resolution of conventional imaging differentiates CADASIL from other disorders of the central nervous system, including subcortical atherosclerotic encephalopathy,28 systemic immune-mediated disease,29 Devic’s neuromyelitis optica,25 and migraine.30 In all these conditions, previous MTI studies did not detect any significant changes outside PD-visible lesions. On the other hand, however, changes at a microscopic level can also be detected by MTI in the NAWM of patients with hydrocephalus,31 multiple sclerosis,23 32 33 multi-infarct dementia,34 amyotrophic lateral sclerosis,35 brain metastases,36 diffuse axonal injury,37 and neuropsychiatric systemic lupus erythematosus.38 Some of the latter conditions may also be in differential diagnosis with CADASIL. NAWM damage is less prominent in the infratentorial regions of individuals with CADASIL, where MTR values did not significantly differ from those of healthy control subjects. This finding confirms and extends previous studies using conventional MRI, which showed PD infratentorial lesions to be relatively rare in individuals with CADASIL5 6 8 9 11 and may also have important diagnostic implications. CADASIL and multiple sclerosis indeed have similar patterns of PD-weighted abnormalities, but infratentorial NAWM has significantly lower MTR in patients with multiple sclerosis than in control subjects.39 The nature and origin of the subtle changes in the NAWM from individuals with CADASIL remain subject to speculation. Low MTR values correlate with histopathologic findings of myelin loss and axon destruction,40 but edema and inflammation can also result in slightly decreased MTR values.41 Considering that vasogenic edema may occur in CADASIL and that edema of sufficient severity or duration can lead to myelin loss, the most tempting explanation is that demyelination is the likely substrate of the MTR changes that we found in the NAWM. However, we also found strong correlations between average MTR of the NAWM and PD lesion volume, T1 lesion volume, and average lesion MTR. This suggests that wallerian degeneration secondary to axonal injury within severely damaged PD-visible lesions might, at least partially, contribute to the NAWM changes that we detected.

MTR values from ROIs occurring in different gray matter structures of individuals with CADASIL were also reduced compared with those of normal control subjects. In individuals with CADASIL, MTR values from the NAGM might have been reduced by partial volume averaging from enlarged CSF spaces, because of the possible presence of cortical atrophy; however, we believe that the differences we found were not driven by such an effect for 2 reasons. First, MTR reductions were not limited to cortical regions, but they were also found in deep gray matter regions. Second, our analysis was carefully conducted by using a small ROI size to minimize partial volume averaging. Our findings agree with previous pathological reports showing the presence of subtle cortical changes, such as neuronal rarefaction and fibrillary gliosis, in individuals with CADASIL.2 42 43 Interestingly, MTR of the NAGM was found to be normal in patients with subcortical atherosclerotic encephalopathy,28 who have conventional MRI abnormalities similar to those found with CADASIL. Admittedly, the role of subtle white and gray matter pathology in CADASIL warrants further elucidation. However, its assessment might be important in the screening of asymptomatic individuals, or its change over time might be used as an earlier marker of disease evolution in longitudinal studies.

Previous studies have attempted to quantify the severity of lesion changes in individuals with CADASIL by measuring the volume of hypointense lesions on T1-weighted scans.7 11 Although areas of hypointense signal on T1-weighted images correspond to areas where demyelination, axonal loss, and prominent reactive gliosis have occurred,44 the assessment of these abnormalities is highly operator dependent and does not provide a quantitative measure of tissue damage within individual lesions. On the contrary, MTR is a quantitative and operator-independent measure, which has been shown to correlate strongly with the degree of axonal and myelin loss.40 We have found that average lesion MTR from individuals with CADASIL is markedly decreased compared with NAWM-MTR and that average lesion MTR varies greatly from patient to patient. In conjunction with variable lesion extent7 and location,11 our findings indicate that variable severity of intrinsic lesion pathology may also contribute to the known variability of the clinical manifestations of CADASIL.5 18 This further argues in favor of a quantitative approach to monitor CADASIL evolution that is either natural or modified by treatment.

In the present study, we obtained MTR histograms of the whole-brain tissue. MTR histogram analysis allows evaluation of data from all the image pixels of the brain tissue, thus providing a complete assessment of CADASIL pathology, including PD-visible lesions, NAWM, and NAGM. We also obtained MTR histograms of the NABT only, by accurately removing from the coregistered MTR maps all the pixels known to belong to PD-visible lesions. We found that (1) average MTR values and peak locations of the histograms were significantly lower in individuals with CADASIL than in control subjects, and (2) in individuals with CADASIL, average MTR of whole-brain tissue was significantly lower than that of NABT. This confirms that most of the brain tissue is affected in CADASIL and that CADASIL pathology is more severe within rather than outside PD-visible lesions. Interestingly, the peak heights of the whole-brain and NABT histograms were not significantly different between control subjects and individuals with CADASIL. MTR histogram peak height is considered a measure of the amount of tissue at "truly" normal MTR values.12 15 23 As a consequence, our findings suggest that changes in the brain of individuals with CADASIL, although severe enough to determine a reduction of average MTR values and peak locations of the histograms, are not diffuse enough to result in a reduction of the peak height. Clearly, with such an approach, information related to the status of specific brain structures or tissues is lost. However, the demonstration that MTR histogram-derived metrics are sensitive measures of tissue damage in CADASIL is important, considering the relatively large number of affected individuals (120 European CADASIL families have been identified in the last few years) and the potential for effective treatments.7 In the context of clinical trials, it may be unfeasible to measure MTR changes from several different brain regions and tissues, and such an analysis is potentially difficult to interpret. A quantitative measure reflecting overall lesion burden, such as average MTR from whole-brain tissue, might be more desirable and represent a useful additional outcome measure.

We also investigated correlations between MTI changes and clinical characteristics in CADASIL. We found that increasing age is significantly correlated with decreasing average MTR from all the tissues studied apart from NAGM. This confirms and extends previous observations,7 9 11 showing that increasing age is associated not only with increasing total lesion volumes but also with increased tissue damage within and outside such lesions. Using univariate correlation analysis, we also found that MTR values from NAWM, NABT, lesions, and whole-brain tissue are significantly correlated with physical disability and cognitive impairment. In addition, multivariate analysis showed that average lesion MTR is the single most relevant MTR quantity correlated with both these clinical measures of disease severity. These findings suggest that the amount and the severity of the affected brain tissue are critical factors in determining the clinical status in CADASIL. The correlations found between MTR-derived metrics and the clinical manifestations of CADASIL indicate the potential for quantitative MR techniques in monitoring the evolution of CADASIL.


*    Acknowledgments
 
We are grateful to Dr M.P. Sormani for her help in conducting the statistical analysis and to Dr M.A. Horsfield for revising the manuscript language.

Received July 27, 2000; revision received December 1, 2000; accepted December 1, 2000.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
up arrowResults
up arrowDiscussion
*References
 

  1. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cécillion M, Maréchal E, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383:707–710.[Medline] [Order article via Infotrieve]
  2. Ruchoux MM, Guerounaou D, Vandenhaute B, Pruvo JP, Vermersch P, Leys D. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol. 1995;89:500–512.[Medline] [Order article via Infotrieve]
  3. Ebke M, Dichgans M, Bergmann M, Voelter HU, Rieger P, Gasser T, Schwendemann G. CADASIL: skin biopsy allows diagnosis in early stages. Acta Neurol Scand. 1997;95:351–357.[Medline] [Order article via Infotrieve]
  4. Ruchoux MM, Maurage CA. CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol. 1997;56:947–964.[Medline] [Order article via Infotrieve]
  5. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, Krebs MO, Julien J, Dubois B, Ducrocq X, et al. Clinical spectrum of CADASIL: a study of 7 families: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet. 1995;346:934–939.[Medline] [Order article via Infotrieve]
  6. Sabbadini G, Francia A, Calandriello L, Di Biasi C, Trasimeni G, Gualdi GF, Palladini G, Manfredi M, Frontali M. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL): clinical, neuroimaging, pathological and genetic study of a large Italian family. Brain. 1995;118:207–215.[Abstract/Free Full Text]
  7. Dichgans M, Filippi M, Brüning R, Iannucci G, Berchtenbreiter C, Minicucci L, Uttner I, Crispin A, Ludwig H, Gasser T, et al. Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology. 1999;52:1361–1367.[Abstract/Free Full Text]
  8. Hutchinson M, O’Riordan J, Javed M, Quin E, Macerlaine D, Willcox T, Parfrey N, Nagy TG, Tournier-Lasserve E. Familial hemiplegic migraine and autosomal dominant arteriopathy with leukoencephalopathy (CADASIL). Ann Neurol. 1995;38:817–824.[Medline] [Order article via Infotrieve]
  9. Chabriat H, Levy C, Taillia H, Iba-Zizen MT, Vahedi K, Joutel A, Tournier-Lasserve E, Bousser MG. Patterns of MRI lesions in CADASIL. Neurology. 1998;51:452–457.[Abstract/Free Full Text]
  10. Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Shungu DC, Naini AB, Mohr JP. CADASIL in a North American family: clinical, pathologic, and radiologic findings. Neurology. 1998;51:844–849.[Abstract/Free Full Text]
  11. Yousry TA, Seelos K, Mayer M, Brüning R, Uttner I, Dichgans M, Mammi S, Straube A, Mai N, Filippi M. Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). AJNR Am J Neuroradiol. 1999;20:91–100.[Abstract/Free Full Text]
  12. Filippi M, Grossman RI, Comi G, eds. Magnetization transfer imaging in multiple sclerosis. Neurology. 1999;53(suppl 3).
  13. Wolff SD, Balaban RS. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med. 1989;10:135–144.[Medline] [Order article via Infotrieve]
  14. McGowan JC. The physical basis of magnetization transfer imaging. Neurology. 1999;53(suppl 3):S3–S7.
  15. van Buchem MA, McGowan JC, Kolson DL, Polansky M, Grossman RI. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med. 1996;36:632–636.[Medline] [Order article via Infotrieve]
  16. Ruchoux MM, Chabriat H, Bousser MG, Baudrimont M, Tournier-Lasserve E. Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke. 1994;25:2291–2292.[Medline] [Order article via Infotrieve]
  17. Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssière C, Cruaud C, Maciazek J, Weisswnbach J, Bousser MG, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350:1511–1515.[Medline] [Order article via Infotrieve]
  18. Dichgans M, Mayer M, Uttner I, Brüning R, Müller-Höcker J, Rungger G, Ebke M, Klochgether T, Gasser T. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44:731–739.[Medline] [Order article via Infotrieve]
  19. De Haan R, Limburg M, Bossuyt P, van der Meulen J, Aaron-Son N. The clinical meaning of Rankin "handicap" grades after stroke. Stroke. 1995;26:2027–2030.[Abstract/Free Full Text]
  20. Zaudig M, Mittelhammer J, Hiller W, Pauls A, Thora C, Morinigo A, Mombour W. SIDAM: a structured interview for the diagnosis of the Alzheimer type, multi-infarct dementia and dementia of other aetiology according to ICD-10 and DSM-III-R. Psychol Med. 1991;21:225–235.[Medline] [Order article via Infotrieve]
  21. Silver NC, Barker GJ, MacManus DG, Tofts PS, Miller DH. Magnetisation transfer ratio of normal brain white matter: a normative database spanning four decades of life. J Neurol Neurosurg Psychiatry. 1997;67:223–228.[Abstract/Free Full Text]
  22. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: Concerted Action Guidelines. J Neurol Neurosurg Psychiatry. 1991;54:683–688.[Abstract]
  23. Filippi M, Iannucci G, Tortorella C, Minicucci L, Horsfield MA, Colombo B, Sormani MP, Comi G. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology. 1999;52:588–594.[Abstract/Free Full Text]
  24. Studholme C, Hill DLG, Hawkes DJ. Automated 3D registration of MR and PET brain images by multi-resolution optimisation of voxel similarity measures. Med Phys. 1997;24:25–35.[Medline] [Order article via Infotrieve]
  25. Filippi M, Rocca MA, Moiola L, Martinelli V, Ghezzi A, Capra R, Salvi F, Comi G. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic’s neuromyelitis optica. Neurology. 1999;53:1705–1710.[Abstract/Free Full Text]
  26. Rovaris M, Filippi M, Calori G, Colombo B, Campi A, Rodegher M, Comi G. Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol. 1997;244:266–270.[Medline] [Order article via Infotrieve]
  27. Sormani MP, Iannucci G, Rocca MA, Mastronardo G, Cercignani M, Minicucci L, Filippi M. Reproducibility of MTR histogram-derived measures of the brain in healthy volunteers. AJNR Am J Neuroradiol. 2000;21:133–136.[Abstract/Free Full Text]
  28. Tanabe JL, Ezekiel F, Jagust WJ, Reed BR, Norman D, Schuff N, Weiner MW, Chui H, Fein G. Magnetization transfer ratio of white matter hyperintensities in subcortical ischemic vascular dementia. AJNR Am J Neuroradiol. 1999;20:839–844.[Abstract/Free Full Text]
  29. Rovaris M, Viti B, Ciboddo G, Gerevini S, Capra R, Iannucci G, Comi G, Filippi M. Brain involvement in systemic immune-mediated diseases: a magnetic resonance and magnetization transfer imaging study. J Neurol Neurosurg Psychiatry. 2000;68:170–177.[Abstract/Free Full Text]
  30. Rocca MA, Colombo B, Pratesi A, Comi G, Filippi M. A magnetization transfer imaging study of brain in patients with migraine. Neurology. 2000;54:507–509.[Abstract/Free Full Text]
  31. Hahnel S, Munkel K, Jansen O, Heiland S, Reidel M, Freund M, Aschoff A, Sartor K. Magnetization transfer measurements in normal-appearing cerebral white matter in patients with chronic obstructive hydrocephalus. J Comput Assist Tomogr. 1999;23:516–520.[Medline] [Order article via Infotrieve]
  32. Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology. 1995;196:511–515.[Abstract/Free Full Text]
  33. Pike GB, De Stefano N, Narayanan S, Worsley KJ, Pelletier D, Francis GS, Antel JP, Arnold DL. Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology. 2000;215:824–830.[Abstract/Free Full Text]
  34. Hanyu H, Imon Y, Asano T, Iwamoto T, Takasaki M. Magnetization transfer imaging of periventricular white matter lesions in patients with multi-infarct dementia. Rinsho Shinkeigaku. 1998;38:412–417.[Medline] [Order article via Infotrieve]
  35. Kato Y, Matsumura K, Kinosada Y, Narita Y, Kuzuhara S, Nakagawa T. Detection of pyramidal tract lesions in amyotrophic lateral sclerosis with magnetization-transfer measurements. AJNR Am J Neuroradiol. 1997;18:1541–1547.[Abstract]
  36. Boorstein JM, Wong KT, Grossman RI, Bolinger L, McGowan JC. Metastatic lesions of the brain: imaging with magnetization transfer. Radiology. 1994;191:799–803.[Abstract/Free Full Text]
  37. Bagley LJ, McGowan JC, Grossman RI, Sinson G, Kotapka M, Lexa FJ, Berlin JA, McIntosh TK. Magnetization transfer imaging of traumatic brain injury. J Magn Reson Imaging. 2000;11:1–8.[Medline] [Order article via Infotrieve]
  38. Bosma GP, Rood MJ, Zwinderman AH, Huizinga TW, van Buchem MA. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging. Arthritis Rheum. 2000;43:48–54.[Medline] [Order article via Infotrieve]
  39. Iannucci G, Minicucci L, Rodegher M, Sormani MP, Comi G, Filippi M. Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T1, T2 and MT histograms. J Neurol Sci. 1999;171:121–129.[Medline] [Order article via Infotrieve]
  40. vanWaesberghe JHTM, Kamphorst W, De Groot CJA, van Walderveen MA, Castelijns JA, Ravid R, Lycklama à Nijeholt GJ, van der Valk P, Polman CH, et al. Axonal loss in MS lesions: MR insights into substrates of disability. Ann Neurol. 1999;46:747–754.[Medline] [Order article via Infotrieve]
  41. Dousset V, Grossman RI, Ramer KN, Schnall MD, Young LH, Gonzalez Scarano F, Lavi E, Cohen JA. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetisation transfer imaging. Radiology. 1992;182:483–491.[Abstract/Free Full Text]
  42. Sourander P, Walinder J. Hereditary multi-infarct dementia: morphological and clinical studies of a new disease. Acta Neuropathol. 1997;39:247–254.[Medline] [Order article via Infotrieve]
  43. Malandrini A, Carrera P, Palmeri S, Cavallaro T, Fabrizi GM, Villanova M, Fattaposta M, Vismara L, Brancolini V, Tanganelli P, et al. Clinicopathological and genetic studies of two further Italian families with cerebral autosomal dominant arteriopathy. Acta Neuropathol. 1996;92:115–122.[Medline] [Order article via Infotrieve]
  44. vanWalderveen MAA, Kamphorst W, Scheltens Ph, van Waesberghe JHTM, Ravid R, Valk J, Polman CH, Barkhof F. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MR in multiple sclerosis. Neurology. 1998;50:1282–1288. [Abstract/Free Full Text]



This article has been cited by other articles:


Home page
StrokeHome page
T. Tourdias, V. Dousset, I. Sibon, E. Pele, P. Menegon, J. Asselineau, C. Pachai, F. Rouanet, P. Robinson, G. Chene, et al.
Magnetization Transfer Imaging Shows Tissue Abnormalities in the Reversible Penumbra
Stroke, December 1, 2007; 38(12): 3165 - 3171.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. K. Liem, J. van der Grond, J. Haan, R. van den Boom, M. D. Ferrari, Y. M. Knaap, M. H. Breuning, M. A. van Buchem, H. A.M. Middelkoop, and S. A.J. Lesnik Oberstein
Lacunar Infarcts Are the Main Correlate With Cognitive Dysfunction in CADASIL
Stroke, March 1, 2007; 38(3): 923 - 928.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
Q Y Gong, P R Eldridge, A R Brodbelt, M Garcia-Finana, A Zaman, B Jones, and N Roberts
Quantification of tumour response to radiotherapy
Br. J. Radiol., May 1, 2004; 77(917): 405 - 413.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. A. Rocca, F. Agosta, D. M. Mezzapesa, V. Martinelli, F. Salvi, A. Ghezzi, R. Bergamaschi, G. Comi, and M. Filippi
Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica
Neurology, February 10, 2004; 62(3): 476 - 478.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
D. M. Mezzapesa, M. A. Rocca, E. Pagani, G. Comi, and M. Filippi
Evidence of Subtle Gray-Matter Pathologic Changes in Healthy Elderly Individuals With Nonspecific White-Matter Hyperintensities
Arch Neurol, August 1, 2003; 60(8): 1109 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Dichgans, B. Putz, D. Boos, and D. P. Auer
Role of Subvoxel Free Fluid on Diffusion Parameters in Brain Tissue with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy and Its Correlation with Physical Disability: Histogram Analysis of Standard and Fluid-Attenuated MR Diffusion
AJNR Am. J. Neuroradiol., June 1, 2003; 24(6): 1083 - 1089.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. Tatsch, W. Koch, R. Linke, G. Poepperl, N. Peters, M. Holtmannspoetter, and M. Dichgans
Cortical Hypometabolism and Crossed Cerebellar Diaschisis Suggest Subcortically Induced Disconnection in CADASIL: An 18F-FDG PET Study
J. Nucl. Med., June 1, 2003; 44(6): 862 - 869.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Inglese, N. DeStefano, E. Pagani, M. T. Dotti, G. Comi, A. Federico, and M. Filippi
Quantification of Brain Damage in Cerebrotendinous Xanthomatosis with Magnetization Transfer MR Imaging
AJNR Am. J. Neuroradiol., March 1, 2003; 24(3): 495 - 500.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
N. Molko, S. Pappata, J.-F. Mangin, F. Poupon, D. LeBihan, M.-G. Bousser, and H. Chabriat
Monitoring Disease Progression in CADASIL With Diffusion Magnetic Resonance Imaging: A Study With Whole Brain Histogram Analysis
Stroke, December 1, 2002; 33(12): 2902 - 2908.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Dichgans, M. Holtmannspotter, J. Herzog, N. Peters, M. Bergmann, and T. A. Yousry
Cerebral Microbleeds in CADASIL: A Gradient-Echo Magnetic Resonance Imaging and Autopsy Study
Stroke, January 1, 2002; 33(1): 67 - 71.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iannucci, G.
Right arrow Articles by Filippi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iannucci, G.
Right arrow Articles by Filippi, M.
Right arrowPubmed/NCBI databases
*Genetics Home Reference
Medline Plus Health Information
*MRI Scans
Related Collections
Right arrow Genetics of Stroke
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Pathology of Stroke